Share Email Print

Proceedings Paper

Photodynamic therapy in early esophageal squamous cell carcinoma
Author(s): Pasquale Spinelli; Marco Dal Fante; Andrea Mancini; Renato Massetti; Emmanuele Meroni
Format Member Price Non-Member Price
PDF $17.00 $21.00

Paper Abstract

From 1/1985 to 7/1993, 18 patients underwent endoscopic photodynamic therapy (PDT) for early stage esophageal squamous cell carcinoma -- as two patients had two synchronous esophageal cancers, 20 lesions were treated. Tumors were staged as Tis in 7 cases and T1 in 13. The average light energy delivered was 50 J/cm2 and 70 J/cm2 for the treatment of Tis and T1, respectively. To obtain a more uniform distribution of laser light in 12 cases the irradiation was performed through the wall of a transparent tube previously placed over the endoscope and advanced into the stomach. The overall results show a complete response in 14/20 (70%) tumors. Three patients developed a local recurrence, 6, 12, and 14 months after therapy. After a follow-up of 5 to 75 months, there was no evidence of disease in 10/18 patients (56%). The actuarial survival rate was 95%, 79%, and 26% at 1, 3, and 5 years, respectively. Complications were skin reaction in one patient and esophageal stenosis at the treatment site, that gradually responded to endoscopic bougienage, in 2 patients. Endoscopic PDT proved to be safe and effective in the treatment of superficial carcinoma of the esophagus.

Paper Details

Date Published: 1 March 1995
PDF: 6 pages
Proc. SPIE 2371, 5th International Photodynamic Association Biennial Meeting, (1 March 1995); doi: 10.1117/12.203428
Show Author Affiliations
Pasquale Spinelli, Istituto Nazionale Tumori (Italy)
Marco Dal Fante, Istituto Nazionale Tumori (Italy)
Andrea Mancini, Istituto Nazionale Tumori (Italy)
Renato Massetti, Istituto Nazionale Tumori (Italy)
Emmanuele Meroni, Istituto Nazionale Tumori (Italy)

Published in SPIE Proceedings Vol. 2371:
5th International Photodynamic Association Biennial Meeting
Denis A. Cortese, Editor(s)

© SPIE. Terms of Use
Back to Top
Sign in to read the full article
Create a free SPIE account to get access to
premium articles and original research
Forgot your username?